Impact of the COVID-19 pandemic on treatment patterns for US patients with metastatic solid cancer
|
October 6, 2021
|
PC3I Authors Samuel Takvorian; Daniel Lee; Roger Kim; Ronac Mamtani; Larry Shulman; William Ferrell; Caleb M. Hearn |
medRxiv
|
Impact of the COVID-19 Pandemic on Treatment Patterns for Patients With Metastatic Solid Cancer in the United States
|
December 11, 2021
|
PC3I Authors Samuel Takvorian; Daniel Lee; Roger Kim; Caleb M. Hearn; William Ferrell; Larry Shulman; Ronac Mamtani |
Journal of the National Cancer Institute
|
Racial Disparities in Adherence to Annual Lung Cancer Screening and Recommended Follow-Up Care: A Multicenter Cohort Study
|
February 15, 2022
|
PC3I Authors Roger Kim; Katharine Rendle; Anil Vachani |
Annals of the American Thoracic Society
|
Artificial Intelligence Tool for Assessment of Indeterminate Pulmonary Nodules Detected with CT
|
May 24, 2022
|
PC3I Authors Roger Kim; Anil Vachani |
Radiology
|
Diagnostic Yield of Cone-beam-Derived Augmented Fluoroscopy and Ultrathin Bronchoscopy Versus Conventional Navigational Bronchoscopy Techniques
|
August 3, 2022
|
PC3I Authors Roger Kim; Anil Vachani |
Journal of Bronchology and Interventional Pulmonology
|
Socioeconomic Status as a Mediator of Racial Disparity in Annual Lung Cancer Screening Adherence
|
October 28, 2022
|
PC3I Authors Roger Kim; Katharine Rendle; Anil Vachani |
American Journal of Respiratory and Critical Care Medicine
|
Effect of an artificial intelligence tool on management decisions for indeterminate pulmonary nodules
|
April 5, 2023
|
PC3I Authors Roger Kim; Anil Vachani |
Respirology
|
Social vulnerability and lung malignancy mortality
|
November 17, 2023
|
PC3I Authors Roger Kim |
Journal of Cancer Policy
|
Rates of Downstream Procedures and Complications Associated With Lung Cancer Screening in Routine Clinical Practice : A Retrospective Cohort Study
|
January 1, 2024
|
PC3I Authors Katharine Rendle; Anil Vachani; Roger Kim; Jocelyn Wainwright |
Annals of Internal Medicine
|
Radiomics and artificial intelligence for risk stratification of pulmonary nodules: Ready for primetime?
|
March 1, 2024
|
PC3I Authors Roger Kim |
Cancer Biomarkers
|
Comparative effectiveness of second-line immune checkpoint inhibitor therapy versus chemotherapy for malignant pleural mesothelioma
|
July 28, 2021
|
PC3I Authors Roger Kim; Anil Vachani; Katharine Rendle |
Lung Cancer
|